Announcement on Using Idle Raised Funds to Temporarily Supplement Current Capital
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
Link of Full Text for Reference:
Announcement on Using Idle Raised Funds to Temporarily Supplement Current Capital
Filed with SSE · · 4 pages · Chinese
On 6ix: 6ix.com/news/announcement-on-using-idle-raised-funds-to-temporarily-supplement-current-capital-1
Release
Sinopep-Allsino Bio Pharmaceutical Co., Ltd. on 6ix
Earlier from Sinopep-Allsino Bio Pharmaceutical
- Announcement on Voluntary Disclosure of Drug GMP Compliance Inspection Passed by Dry Suspension and Granule Production Line in New Oral Solid Preparation Workshop
- Announcement on Returning the Raised Funds Temporarily Used for Supplementing Current Capital in Advance
Later from Sinopep-Allsino Bio Pharmaceutical
- Annual Earnings Preannouncement for 2024
- Announcement on Voluntary Disclosure of Obtaining the Drug Registration Certificate for Ezetimibe and Atorvastatin Calcium Tablets
- Announcement on Voluntary Disclosure of Passing GMP On-site Inspection for Drugs
- Announcement on Preliminary Earnings Estimate for 2024
- Announcement on Voluntary Disclosure of Subsidiary Passing the U.S. FDA On-site Inspection
Follow Sinopep-Allsino Bio Pharmaceutical into a list and get an email when it puts out news.
Follow Sinopep-Allsino Bio Pharmaceutical